Patent: 8,568,766

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,568,766

Title:	Peptides and peptide mimetics to treat pathologies associated with eye disease
Abstract:	This invention provides novel active agents (e.g. peptides, small organic molecules, amino acid pairs, etc.) peptides that ameliorate one or more symptoms of eye disease and/or other pathologies characterized by an inflammatory response. In certain embodiment, the peptides resemble a G* amphipathic helix of apolipoprotein J. The agents are highly stable and readily administered via an oral route or via intraocular injection.
Inventor(s):	Anantharamaiah; Gattadahalli M. (Birmingham, AL), Fogelman; Alan M. (Beverly Hills, CA), Navab; Mohamad (Los Angeles, CA), Rudolf; Martin (Lubeck, DE)
Assignee:
Application Number:	12/027,728
Patent Claims:	see list of patent claims

Details for Patent 8,568,766

Glossary

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	001	2004-02-26	Try a Free Trial		2020-08-24	RX		search
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	002	2004-02-26	Try a Free Trial		2020-08-24	RX		search
Genentech	LUCENTIS	ranibizumab	INJECTABLE; INJECTION	125156	001	2006-06-30	Try a Free Trial		2020-08-24	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 8,568,766

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Publication Date
Austria	464060	Apr 15, 2010
Austria	506958	May 15, 2011
Australia	2001286732	Oct 06, 2005
Australia	2003284129	May 04, 2004
Australia	2004264944	Feb 24, 2005
Australia	2004264944	Mar 10, 2011
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.